Surgery Partners CS (SGRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 239,900 | 269,500 | 195,900 | 282,900 | 389,900 |
| Receivables | 602,200 | 579,100 | 496,400 | 456,300 | 430,200 |
| Inventories | 96,600 | 88,400 | 75,200 | 71,400 | 61,100 |
| Other current assets | 170,900 | 146,000 | 96,500 | 79,000 | 39,300 |
| TOTAL | $1,150,700 | $1,119,400 | $895,000 | $921,000 | $946,100 |
| Non-Current Assets | |||||
| PPE Net | 1,153,400 | 1,088,300 | 968,700 | 876,600 | 629,700 |
| Investments And Advances | 234,000 | 215,400 | 184,100 | 190,300 | 88,700 |
| Intangibles | 5,235,600 | 5,113,700 | 4,380,800 | 4,179,400 | 3,955,500 |
| Other Non-Current Assets | 346,000 | 353,201 | 448,099 | 514,800 | 497,600 |
| TOTAL | $6,969,000 | $6,770,601 | $5,981,699 | $5,761,100 | $5,171,500 |
| Total Assets | $8,119,700 | $7,890,000 | $6,876,700 | $6,682,100 | $6,117,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 99,300 | 101,400 | 73,300 | 62,800 | 60,400 |
| Accounts payable and accrued liabilities | 208,700 | 208,700 | 171,800 | 151,600 | 124,900 |
| Accrued Expenses | 64,900 | 60,400 | 73,800 | 68,900 | 141,500 |
| Other current liabilities | 242,600 | 253,900 | 204,100 | 210,100 | 210,000 |
| TOTAL | $615,500 | $624,400 | $523,000 | $493,400 | $536,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,602,900 | 3,268,900 | 2,701,800 | 2,559,000 | 2,878,400 |
| Other Non-Current Liabilities | 539,800 | 580,500 | 470,200 | 547,200 | 591,200 |
| TOTAL | $4,372,900 | $4,069,200 | $3,319,200 | $3,247,800 | $3,611,200 |
| Total Liabilities | $4,988,400 | $4,693,600 | $3,842,200 | $3,741,200 | $4,148,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 129,420 | 127,613 | 126,607 | 126,028 | 89,357 |
| Common Shares | 1,300 | 1,300 | 1,300 | 1,300 | 900 |
| Retained earnings | -815,200 | -737,300 | -569,200 | -557,300 | -502,700 |
| Other shareholders' equity | 1,404,600 | 1,411,500 | 1,104,800 | 1,018,900 | 849,100 |
| TOTAL | $3,131,300 | $3,196,400 | $3,034,500 | $2,940,900 | $1,969,600 |
| Total Liabilities And Equity | $8,119,700 | $7,890,000 | $6,876,700 | $6,682,100 | $6,117,600 |